Inmune Bio, Inc.
INMB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001711754
No open-market purchases or sales by Inmune Bio, Inc. insiders were filed in the last 90 days; 82 institutions reported holding it in 13F filings for Q2 2026, worth $7.08M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Inmune Bio, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 74 | 1 | 82 | +9 |
| Shares | 5.08M | 957.8K | 5.38M | +1.25M (+30.3%) |
| Value | $7.93M | $1.49M | $6.09M | −$352.0K (−5.5%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Inmune Bio, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 687,015 | $776.3K | 0.00% |
| Vanguard Portfolio Management LLC | 129,218 | $146.0K | 0.00% |
| Vanguard Fiduciary Trust Co | 123,184 | $139.2K | 0.00% |
| Ieq Capital, LLC | 24,563 | $27.8K | 0.00% |
| Modera Wealth Management, LLC | 17,575 | $19.9K | 0.00% |
| Renaissance Technologies LLC | 17,000 | $19.2K | 0.00% |
| Cerity Partners LLC | 14,042 | $15.9K | 0.00% |
| Vanguard Global Advisers, LLC | 4,539 | $5.13K | 0.00% |
| Rothschild Investment LLC | 585 | $661 | 0.00% |
| Allworth Financial LP | 474 | $536 | 0.00% |
| Group One Trading, L.P. | 388 | $438 | 0.00% |
| Root Financial Partners, LLC | 87 | $98 | 0.00% |
| SRS Capital Advisors, Inc. | 66 | $75 | 0.00% |
| Wealth Preservation Advisors, LLC | 60 | $68 | 0.00% |
| Farther Finance Advisors, LLC | 52 | $64 | 0.00% |
| True Wealth Design, LLC | 11 | $13 | 0.00% |
| SJS Investment Consulting Inc. | 9 | $11 | 0.00% |
| Caitong International Asset Management Co., Ltd | 3 | $3 | 0.00% |
Sold out (9)
Institutions that held Inmune Bio, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Jain Global LLC | 42,051 | $65.6K |
| Bank of Montreal | 25,987 | $40.5K |
| Virtu Financial LLC | 20,388 | $32.0K |
| Cary Street Partners Financial LLC | 13,917 | $21.7K |
| California State Teachers Retirement System | 1,256 | $1.96K |
| Union Bancaire Privee, UBP SA | 1,000 | $1.36K |
| Amalgamated Bank | 641 | $1.00K |
| Assetmark, Inc | 150 | $234 |
| Steward Partners Investment Advisory, LLC | 5 | $8 |
Not filed for Q1 2026 yet (1)
Institutions that held Inmune Bio, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 957,846 | $1.49M |